HALO logo
halo search icon
Jade Biosciences, Inc.
Jade Biosciences, Inc.
JBIO · NAS

Jade Biosciences, Inc.

US$23.34

Price Arrow1.46 (6.67%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakupFakey Shakey - ShortFakey Shakey - Short (Realtime)HALO AllHammer Bearish (Realtime)Recent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Jade Biosciences, Inc. Overview

JBIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About JBIO

icon

Website

Jade Biosciences, Inc.

icon

Telephone

1.617.443.2400

icon

Address

Suite 105, 221 Crescent Street, Building 23, Waltham, MA 02453

Description

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

JBIO Price Chart

Key Stats

Market Cap

US$1.08B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

29-Apr-25

Market Data

52 weeks range

Low 6.57 - 28

Trade Value (12mth)

US$1,226,612.00

1 week

-6.32%

1 month

-4.91%

YTD

54.52%

1 year

192.12%

All time high

1134.53

Key Fundamentals

EPS 3 yr Growth

-94.50%

EBITDA Margin

0.00%

Operating Cashflow

-$95m

Free Cash Flow Return

-46.20%

ROIC

-62.20%

Interest Coverage

0.00

Quick Ratio

21.10

Other Data

Shares Outstanding (Fully Diluted)

58m

HALO Sector

Healthcare

Next Company Report Date

31-Mar-27

Next Ex Dividend Date

29-Apr-25

Next Dividend Pay Date

28-Apr-25

Reporting Currency

USD

Short Sell (% of issue)

0.00

JBIO Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

JBIO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-100.38-85.26-4.06locklocklock
EPS (Fully Diluted)
$locklocklocklock-100.38-85.26-4.06locklocklock
Growth
%locklocklocklock-36.315.195.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

29-Apr-25

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Jade Biosciences, Inc. (JBIO:NAS)?
Halo FAQ
The current share price of Jade Biosciences, Inc. (JBIO:NAS) is USD$23.34.
What is the 52-week high share price for Jade Biosciences, Inc. (JBIO:NAS)?
Halo FAQ
The 52-week high share price for Jade Biosciences, Inc. (JBIO:NAS) is USD$28.00.
What is the 52-week low share price for Jade Biosciences, Inc. (JBIO:NAS)?
Halo FAQ
The 52-week low share price for Jade Biosciences, Inc. (JBIO:NAS) is USD$6.57.
What is the dividend yield for Jade Biosciences, Inc. (JBIO:NAS)?
Halo FAQ
Jade Biosciences, Inc. (JBIO:NAS) does not pay a dividend.
What was Jade Biosciences, Inc. (JBIO:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Jade Biosciences, Inc. (JBIO:NAS) is USD$2.40.
What is the franking level for Jade Biosciences, Inc. (JBIO:NAS)?
Halo FAQ
Jade Biosciences, Inc. (JBIO:NAS) has a franking level of 0.00%.
In which sector is Jade Biosciences, Inc. (JBIO:NAS) classified?
Halo FAQ
Jade Biosciences, Inc. (JBIO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.